申请人:Rhone-Poulenc Rorer S.A.
公开号:US05739351A1
公开(公告)日:1998-04-14
New perhydroinsoindole having the general formula (I) wherein R.sub.1 is optionally substituted phenyl or is cyclohexadienyl, naphtyl, indenyl or mono or polycyclic heterocyclyl, saturated or unsaturated 5 to 9C and optionally substituted, R.sub.2 is H or halogen, OH, alkyl, amino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, alkyloxy, alkylthio, acyloxy, carboxy, alkyloxycarbonyl, dialkylaminoalcyloxycarbonyl, benzyloxycarbonyl, amino or acylamino, R.sub.3 is phenyl optionally substituted in position -2 by a radical alkyl or alkyloxy 1 or 2C or by OH or F, or disubstituted by CF.sub.3, and R.sub.4 is an alkyl radical containing 1 or 2C substituted by halogen or CN, N.sub.3 or --NHCN, and the radicals R which are similar or different represent H, alkyl or phenyl, in their isomer forms having the structure (Ia) or mixtures thereof, optionally their salts when they exist and preparation thereof. The new derivatives of the invention are particularly useful as antagonists of substance P.
新的过氢化异吲哚具有通式(I),其中R.sub.1是可选取代苯基或环己二烯基、萘基、茚基或单环或多环杂环基,饱和或不饱和5到9C并可选取代,R.sub.2是H或卤素、OH、烷基、氨基、氨基烷基、烷基氨基烷基、二烷基氨基烷基、烷氧基、烷硫基、酰氧基、羧基、烷氧羰基、二烷基氨基羰氧基、苄氧羰基、氨基或酰胺基,R.sub.3是苯基,可选取代于位置-2上的基团烷基或烷氧基1或2C或OH或F,或被CF.sub.3二取代,R.sub.4是含有1或2C的烷基,被卤素或CN、N.sub.3或--NHCN取代,以及相似或不同的基团R,代表H、烷基或苯基,在它们的异构体形式中具有结构(Ia)或其混合物,选用它们的盐(如果存在)及其制备方法。本发明的新衍生物特别适用于作为物质P的拮抗剂。